GWM
THER

Geneos Wealth Management’s THERATECHNOLOGIES INC COM THER Stock Holding History

Geneos Wealth Management’s Portfolio THER Stock Details THER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,600
Closed -$5K – 2654
2020
Q1 		$5K Hold
3,600
– – ﹤0.01% 2077
2019
Q4 		$10K Buy
+3,600
New +$10K ﹤0.01% 1996

Other funds holding THER

Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geneos Wealth Management's THER Position: Q2 2020 in Review

Geneos Wealth Management sold out of THERATECHNOLOGIES INC COM (THER) in Q2 2020, closing a stake of 3,600 shares — an estimated $5K sold.

Geneos Wealth Management first reported a position in THER in Q4 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 36 funds tracked by Wall St. Rank hold THER as of Q2 2020.

  • Geneos Wealth Management reported no remaining THERATECHNOLOGIES INC COM position as of Q2 2020 after selling out during the quarter.
  • Geneos Wealth Management sold 3,600 THERATECHNOLOGIES INC COM shares in Q2 2020, an estimated $5K.
  • Geneos Wealth Management first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 2 quarters.
  • Geneos Wealth Management's THERATECHNOLOGIES INC COM position peaked at $10K in Q4 2019.
  • 36 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q2 2020.

Based on Geneos Wealth Management's 13F filing for Q2 2020, filed 7 Sep 2021.